Draft:Mind Medicine Australia

Mind Medicine Australia is a not-for-profit organization based in Melbourne, Australia, dedicated to advancing psychedelic-assisted therapies for mental illness. Founded in 2019 by Tania de Jong AM and Peter Hunt AM, the organization aims to alleviate the suffering caused by mental illness through the integration of psychedelic medicines into mainstream mental health care.

Overview
Mind Medicine Australia advocates for the therapeutic potential of psychedelic substances such as psilocybin, MDMA, and ketamine, based on evidence-based research.. . These substances have shown promise in clinical trials for various mental health conditions, including depression, post-traumatic stress disorder (PTSD) , anxiety disorders , and substance use disorders

Activities
Mind Medicine Australia conducts educational programs, workshops, and conferences to raise awareness about the benefits of psychedelic-assisted therapies among the general public, healthcare professionals, and policymakers. Additionally, the organization advocates for regulatory reforms to facilitate safe and legal access to these therapies for those in need.

One of the key initiatives of Mind Medicine Australia is the training of healthcare professionals in psychedelic-assisted therapy protocols. The organization offers educational programs and certification courses for therapists, doctors, and other healthcare practitioners interested in incorporating psychedelic-assisted treatments into their clinical practice.

Furthermore, Mind Medicine Australia supports and funds research projects investigating the safety and efficacy of psychedelic-assisted therapies. By contributing to the growing body of scientific evidence, the organization aims to build a strong case for the integration of these therapies into mainstream mental health care.

In February 2023, Mind Medicine Australia's rescheduling submission to the Therapeutic Goods Administration (TGA) led to the rescheduling of Psilocybin for treatment-resistant depression and MDMA for post-traumatic stress disorder. Since July 2023, Psychiatrists who are authorised prescribers have been able to prescribe these medicines in Australia. Australia is the first country in the world to approve MDMA and psilocybin as an authorised medicine